TMCnet News

Research and Markets: Global In-Vitro Diagnostics Market Outlook 2018
[April 23, 2014]

Research and Markets: Global In-Vitro Diagnostics Market Outlook 2018


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/3n7grm/invitro) has announced the addition of the "In-Vitro Diagnostics Market Outlook 2018" report to their offering.

Driven by factors, such as increasing prevalence of chronic diseases, rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the market is dominated by developed countries; however, rising economies such as India, Brazil and China are likely to witness strong growth in the coming years.

In the latest research study, In-Vitro Diagnostics Market Outlook 2018, RNCOS analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 55.4 Billion in 2013, is expected to grow at a CAGR of around 7% during 2013-2018.

The market has been segmented keeping in mind three factors: Clinical use, Geographical scenario and Player specializations, and for every segment a current and future outlook to 2018 has been provided. For regional analysis, key IVD markets that together constitute around 95% of the global market, have been profiled. Through this research, opportunity assessment in various segments has been performed and the segments that offer the maximum opportunity for growth have been highlighted.



Key Topics Covered:

1. Analyst View


2. Research Methodology

3. In Vitro Diagnostic Market Overview

4. Clinical Segmentation Outlook 2018

  • Point-of-Care Diagnostics
  • Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Microbiology
  • Hemostasis
  • Immunohematology

5. Geographical Segmentation (Current & Future Scenario - 2018)

6. Industry Trends

  • Fast Emerging Niche: Devices to Capture Circulating Tumor Cells
  • On the Horizon: Non-Invasive Genetic Tests for Cancer
  • Non-Invasive Prenatal Diagnostics Market Witnesses Boom
  • Companion Diagnostics Partnerships Gear Up
  • Predictive Cancer Diagnostic Test Market Rockets Northwards
  • POCT: Expanding Avenues into Multiple Disease Diagnosis

7. Competitive Landscape

  • Abbott Laboratories
  • Alere, Inc.
  • Becton Dickinson
  • Bayer HealthCare
  • Beckman Coulter
  • Biomerieux
  • Johnson and Johnson
  • Life Technologies Corporation
  • Medtronic, Inc.
  • Qiagen NV
  • Roche Holding Ltd
  • Sysmex Corporation
  • Siemens (News - Alert) HealthCare
  • Thermo Fisher Scientific

For more information visit http://www.researchandmarkets.com/research/3n7grm/invitro


[ Back To TMCnet.com's Homepage ]